HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

HNK-1 glycan functions as a tumor suppressor for astrocytic tumor.

Abstract
Astrocytic tumor is the most prevalent primary brain tumor. However, the role of cell surface carbohydrates in astrocytic tumor invasion is not known. In a previous study, we showed that polysialic acid facilitates astrocytic tumor invasion and thereby tumor progression. Here, we examined the role of HNK-1 glycan in astrocytic tumor invasion. A Kaplan-Meier analysis of 45 patients revealed that higher HNK-1 expression levels were positively associated with increased survival of patients. To determine the role of HNK-1 glycan, we transfected C6 glioma cells, which lack HNK-1 glycan expression, with β1,3-glucuronyltransferase-P cDNA, generating HNK-1-positive cells. When these cells were injected into the mouse brain, the resultant tumors were 60% smaller than tumors emerging from injection of the mock-transfected HNK-1-negative C6 cells. HNK-1-positive C6 cells also grew more slowly than mock-transfected C6 cells in anchorage-dependent and anchorage-independent assays. C6-HNK-1 cells migrated well after treatment of anti-β1 integrin antibody, whereas the same treatment inhibited cell migration of mock-transfected C6 cells. Similarly, α-dystroglycan containing HNK-1 glycan is different from those containing the laminin-binding glycans, supporting the above conclusion that C6-HNK-1 cells migrate independently from β1-integrin-mediated signaling. Moreover, HNK-1-positive cells exhibited attenuated activation of ERK 1/2 compared with mock-transfected C6 cells, whereas focal adhesion kinase activation was equivalent in both cell types. Overall, these results indicate that HNK-1 glycan functions as a tumor suppressor.
AuthorsMisa Suzuki-Anekoji, Masami Suzuki, Tatsuya Kobayashi, Yoshiko Sato, Jun Nakayama, Atsushi Suzuki, Xingfeng Bao, Kiyohiko Angata, Minoru Fukuda
JournalThe Journal of biological chemistry (J Biol Chem) Vol. 286 Issue 37 Pg. 32824-33 (Sep 16 2011) ISSN: 1083-351X [Electronic] United States
PMID21784847 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • Antibodies
  • Antigens, Neoplasm
  • Glucans
  • Integrin beta1
  • Neoplasm Proteins
  • Focal Adhesion Protein-Tyrosine Kinases
  • MAPK1 protein, human
  • Mitogen-Activated Protein Kinase 1
  • Mitogen-Activated Protein Kinase 3
Topics
  • Animals
  • Antibodies (pharmacology)
  • Antigens, Neoplasm (metabolism)
  • Astrocytoma (metabolism, pathology)
  • Brain Neoplasms (metabolism, pathology)
  • Cell Line, Tumor
  • Cell Movement
  • Enzyme Activation (drug effects)
  • Female
  • Focal Adhesion Protein-Tyrosine Kinases (metabolism)
  • Gene Expression Regulation, Neoplastic
  • Glucans (metabolism)
  • Humans
  • Integrin beta1 (metabolism)
  • Male
  • Mice
  • Mice, Nude
  • Mitogen-Activated Protein Kinase 1 (metabolism)
  • Mitogen-Activated Protein Kinase 3 (metabolism)
  • Neoplasm Proteins (metabolism)
  • Neoplasm Transplantation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: